Gilead, J&J to develop once-daily HIV pill (Reuters)
Thursday, July 16th, 2009Reuters – Drug makers Gilead Sciences Inc and Johnson & Johnson on Thursday said they plan to develop the second once-daily pill for treating HIV, the virus that causes AIDs.